MUSTANG BIO, INC. (MBIO)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
No signals recorded in the last 12 months.
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-24 | Litchman Manuel MD | director | F | 19 | 0.75 | $14 |
| 2026-01-02 | Fortress Biotech, Inc. | ten percent owner | A | 278,385 | 0 | $0 |
| 2025-12-30 | Herskowitz Neil | director | S | 247 | 0.96 | $237 |
| 2025-12-30 | Chill Adam J. | director | S | 4 | 0.95 | $4 |
| 2025-12-30 | Jin David | director | P | 247 | 0.96 | $237 |
| 2025-09-29 | Fortress Biotech, Inc. | ten percent owner | A | 59,334 | 0 | $0 |
| 2025-04-24 | Litchman Manuel MD | director | F | 27 | 1.24 | $33 |
| 2025-03-31 | Fortress Biotech, Inc. | ten percent owner | A | 67,806 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-05 10-Q
- 2026-05-05 10-Q
- 2026-04-27 4
- 2026-04-17 8-K
- 2026-03-19 10-K
- 2026-01-05 SCHEDULE 13D/A
- 2026-01-05 4
- 2025-12-30 4
- 2025-12-30 4
- 2025-12-30 4
- 2025-12-23 8-K
- 2025-12-03 DEF 14A
- 2025-11-07 10-Q
- 2025-10-01 SCHEDULE 13D/A
- 2025-10-01 4
- 2025-09-05 424B5
- 2025-08-12 SCHEDULE 13G/A
- 2025-08-08 10-Q
- 2025-07-09 8-K
- 2025-05-15 SCHEDULE 13G/A